Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Health Promotion International and ICARA Contemporary Issues in Academic Publishing: Webinar One: Conflicts of interest in public health and addiction research
About This Webinar
Conflicts of interest (COIs) pose risks to public health research, policy and decision making. They can also create ethical and reputational risks for researchers, including perceptions about the integrity of research. Despite this, expectations about COI declarations are still unclear for many researchers. Who should take responsibility for managing COIs? How should we assess the risks associated with accepting funding from organisations that may be harmful for health? Hosted by Health Promotion International and the International Confederation of Alcohol, Tobacco and Other Drug Research Associations, this panel discussion and Q&A will examine COIs specifically in relation to public health and addiction research and policy making.
Who can view: Everyone
Webinar Price: Free
Featured Presenters
Deakin University
Professor Samantha Thomas is Professor of Public Health at Deakin University, Editor in Chief of Health Promotion International, and a board member of ICARA. Samantha’s research focuses on the commercial and political determinants of health. Her current projects include examining the role of conflicts of interest in policy decision making about women’s health (particularly menopause); the influence of corporate and political interests on climate (in)action; and the impact of marketing and public relations strategies on the normalisation of gambling for young people and women.
Professor Samantha Thomas is Professor of Public Health at Deakin University, Editor in Chief of Health Promotion International, and a board member of ICARA. Samantha’s research focuses on the commercial and political determinants of health. Her current projects include examining the role of conflicts of interest in policy decision making about women’s health (particularly menopause); the influence of corporate and political interests on climate (in)action; and the impact of marketing and public relations strategies on the normalisation of gambling for young people and women.
University of Dundee
Dr. Andrea Mohan is a Lecturer in the School of Health Sciences at the University of Dundee. She is the co-lead of the Substance Use Research Group (SURG) within her department. She is also the president of ICARA. Andy’s research interest spans the field of alcohol and drugs research, from population-level interventions such as alcohol licensing and drink-driving, to an individual focus on harm reduction and recovery. Andy’s research background is in public health, health promotion and behaviour change in socially-deprived populations and she has experience in public engagement.
Dr. Andrea Mohan is a Lecturer in the School of Health Sciences at the University of Dundee. She is the co-lead of the Substance Use Research Group (SURG) within her department. She is also the president of ICARA. Andy’s research interest spans the field of alcohol and drugs research, from population-level interventions such as alcohol licensing and drink-driving, to an individual focus on harm reduction and recovery. Andy’s research background is in public health, health promotion and behaviour change in socially-deprived populations and she has experience in public engagement.
University of Sydney
Adam Dunn (PhD, FAIDH) is a Professor of Biomedical Informatics at the University of Sydney. He established the Discipline of Biomedical Informatics and Digital Health in the Faculty of Medicine and Health and has led the group since 2020. His research is focused mainly on applications of AI in health and medicine, especially to support health communications, clinical evidence synthesis, and the safety and fairness of AI tools used in healthcare.
Adam Dunn (PhD, FAIDH) is a Professor of Biomedical Informatics at the University of Sydney. He established the Discipline of Biomedical Informatics and Digital Health in the Faculty of Medicine and Health and has led the group since 2020. His research is focused mainly on applications of AI in health and medicine, especially to support health communications, clinical evidence synthesis, and the safety and fairness of AI tools used in healthcare.
LSHTM
Dr May van Schalkwyk is a public health doctor and researcher working at the London School of Hygiene and Tropical Medicine. May’s research aims to forward understanding on how the activities of commercial actors influence ideas, knowledge, public discourse, and policy debates. She has published research on the tobacco, alcohol, gambling, and firearms industries, including on the activities of industry funded organisations and their influence on schools and youth education.
Dr May van Schalkwyk is a public health doctor and researcher working at the London School of Hygiene and Tropical Medicine. May’s research aims to forward understanding on how the activities of commercial actors influence ideas, knowledge, public discourse, and policy debates. She has published research on the tobacco, alcohol, gambling, and firearms industries, including on the activities of industry funded organisations and their influence on schools and youth education.
RCSI
Dr. James Larkin is a post-doctoral researcher and honorary lecturer in RCSI University of Medicine and Health Sciences, Ireland. His research focusses on the marketing practices of the pharmaceutical and medical device industries, transparency and management of conflicts of interest and the restrictions healthcare organisations place on these practices. Dr. Larkin holds a PhD in Health Economics from RCSI, where he examined the financial burden of healthcare for people with multimorbidity.
Dr. James Larkin is a post-doctoral researcher and honorary lecturer in RCSI University of Medicine and Health Sciences, Ireland. His research focusses on the marketing practices of the pharmaceutical and medical device industries, transparency and management of conflicts of interest and the restrictions healthcare organisations place on these practices. Dr. Larkin holds a PhD in Health Economics from RCSI, where he examined the financial burden of healthcare for people with multimorbidity.
Inserm (French National Institute of Health and Medical Research)
Dr Mialon is the Inserm Chair of Research on Health Services, at the French School of Public Health (EHESP). She is also a Visiting Research Fellow at Trinity Business School, Trinity College Dublin in Ireland. Dr Mialon co-coordinates the Global Commercial Determinants of health Action Network (GCAN, formerly GECI-PH).
Her research focuses on commercial determinants of health, particularly the practices of corporations that influence public health policy, research and practice.
Dr Mialon is French and Mauritian, with an Indian, African and European background.
Dr Mialon is the Inserm Chair of Research on Health Services, at the French School of Public Health (EHESP). She is also a Visiting Research Fellow at Trinity Business School, Trinity College Dublin in Ireland. Dr Mialon co-coordinates the Global Commercial Determinants of health Action Network (GCAN, formerly GECI-PH).
Her research focuses on commercial determinants of health, particularly the practices of corporations that influence public health policy, research and practice.
Dr Mialon is French and Mauritian, with an Indian, African and European background.
Curtin University
Mike Daube is Emeritus Professor in the Faculty of Health Sciences at Curtin University, where he was Professor of Health Policy and Director of the Public Health Advocacy Institute. Before this he was Director General of Health for Western Australia and Chair of the Australian National Public Health Partnership. He has held many senior positions in government, with further roles including President of the Public Health Association of Australia, President of the Australian Council on Smoking and Health, co-chair of the National Alliance for Action on Alcohol, Chair of the Tobacco Expert Committee that recommended plain packaging and other measures, and many other boards and committees. He has been active nationally and internationally in health policy, tobacco control, alcohol, gambling and other areas in public health for over 50 years. Among other awards, he is an Officer in the Order of Australia (AO), and was the 2018 Western Australian of the Year. He is Chair of the Editorial Board for Health Promotion International.
Mike Daube is Emeritus Professor in the Faculty of Health Sciences at Curtin University, where he was Professor of Health Policy and Director of the Public Health Advocacy Institute. Before this he was Director General of Health for Western Australia and Chair of the Australian National Public Health Partnership. He has held many senior positions in government, with further roles including President of the Public Health Association of Australia, President of the Australian Council on Smoking and Health, co-chair of the National Alliance for Action on Alcohol, Chair of the Tobacco Expert Committee that recommended plain packaging and other measures, and many other boards and committees. He has been active nationally and internationally in health policy, tobacco control, alcohol, gambling and other areas in public health for over 50 years. Among other awards, he is an Officer in the Order of Australia (AO), and was the 2018 Western Australian of the Year. He is Chair of the Editorial Board for Health Promotion International.
Hosted By
Attended
(110)
Recommended